Abstract | BACKGROUND: PURPOSE: METHODS/SEARCH STRATEGY: PubMed and CINAHL were searched using the terms " hydrops fetalis," " congenital," "chylothorax," "neonate," and "preterm." Twenty-two English language articles published within the last five years were identified and included to determine the current body of evidence surrounding treatment options for hydrops fetalis and CC. CASE FINDINGS: IMPLICATIONS FOR PRACTICE: Antenatal intervention may be appropriate for some infants, otherwise supportive medical management including respiratory and nutrition therapies should be prioritized for infants born with hydrops fetalis and CC. IMPLICATIONS FOR RESEARCH:
Nonimmune hydrops fetalis secondary to CC presents a complex challenge for neonatal providers, as no definitive treatment strategy currently exists. Further research is needed to determine the safety and efficacy of controversial therapies including octreotide.
|
Authors | Whitney W Brock, Wanda T Bradshaw |
Journal | Advances in neonatal care : official journal of the National Association of Neonatal Nurses
(Adv Neonatal Care)
Vol. 16
Issue 2
Pg. 114-23
(Apr 2016)
ISSN: 1536-0911 [Electronic] United States |
PMID | 26945279
(Publication Type: Case Reports, Journal Article, Review)
|
Chemical References |
|
Topics |
- Chest Tubes
- Chylothorax
(congenital, diagnostic imaging, therapy)
- Fetal Therapies
(methods)
- Humans
- Hydrops Fetalis
(diagnostic imaging, therapy)
- Infant, Newborn
- Infant, Premature
- Male
- Octreotide
(therapeutic use)
- Pleurodesis
- Radiography, Thoracic
- Respiration, Artificial
- Thoracentesis
(methods)
- Thoracic Duct
(surgery)
- Thoracic Surgery, Video-Assisted
- Ultrasonography, Prenatal
|